{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:15:19Z","timestamp":1792602919630,"version":"4.5.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Viral diseases pose a serious global health threat due to their rapid transmission and widespread impact. The RNA-dependent RNA polymerase (RdRp) participates in the synthesis, transcription, and replication of viral RNA in host. The current study investigates the antiviral potential of secondary metabolites particularly those derived from bacteria, fungi, and plants to develop novel medicines. Using a virtual screening approach that combines molecular docking and molecular dynamics (MD) simulations, we aimed to discover compounds with strong interactions with RdRp of five different retroviruses. The top five compounds were selected for each viral RdRp based on their docking scores, binding patterns, molecular interactions, and drug-likeness properties. The molecular docking study uncovered several metabolites with antiviral activity against RdRp. For instance, cytochalasin Z8 had the lowest docking score of \u20138.9 (kcal\/mol) against RdRp of SARS-CoV-2, aspulvinone D (\u20139.2 kcal\/mol) against HIV-1, talaromyolide D (\u20139.9 kcal\/mol) for hepatitis C, aspulvinone D (\u20139.9 kcal\/mol) against Ebola and talaromyolide D also maintained the lowest docking score of \u20139.2 kcal\/mol against RdRp enzyme of dengue virus. These compounds showed remarkable antiviral potential comparable to standard drug (remdesivir \u20137.4 kcal\/mol) approved to target RdRp and possess no significant toxicity. The molecular dynamics simulation confirmed that the best selected ligands were firmly bound to their respective target proteins for a simulation time of 200 ns. The identified lead compounds possess distinctive pharmacological characteristics, making them potential candidates for repurposing as antiviral drugs against SARS-CoV-2. Further experimental evaluation and investigation are recommended to ascertain their efficacy and potential.<\/jats:p>","DOI":"10.1371\/journal.pone.0307615","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T13:30:43Z","timestamp":1722864643000},"page":"e0307615","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Structure based screening and molecular docking with dynamic simulation of natural secondary metabolites to target RNA-dependent RNA polymerase of five different retroviruses"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4080-3874","authenticated-orcid":true,"given":"Muhammad","family":"Azeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-6496","authenticated-orcid":true,"given":"Ghulam","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibtain","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7199-0118","authenticated-orcid":true,"given":"Muhammad","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Usama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"pone.0307615.ref001","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4018\/IJQSPR.2020040104","article-title":"In Silico Studies of Potentially Active 2-Amino-Thiophenic Derivatives Against HIV-1","volume":"5","author":"AFM Monteiro","year":"2020","journal-title":"International Journal of Quantitative Structure-Property Relationships (IJQSPR)"},{"key":"pone.0307615.ref002","doi-asserted-by":"crossref","first-page":"105497","DOI":"10.1016\/j.micpath.2022.105497","article-title":"Structure-based screening of natural product libraries in search of potential antiviral drug-leads as first-line treatment to COVID-19 infection","volume":"165","author":"SJA Rao","year":"2022","journal-title":"Microbial Pathogenesis"},{"key":"pone.0307615.ref003","article-title":"In silico study of the binding of daunomycin and phenylalanine transfer RNA: probe molecular recognition for structure-based drug design","author":"G Wu","year":"2023","journal-title":"Molecular Systems Design & Engineering"},{"key":"pone.0307615.ref004","doi-asserted-by":"crossref","first-page":"58","DOI":"10.32718\/ujvas5-1.10","article-title":"Pathogenetic aspects of retroviral infections","volume":"5","author":"L Horalskyi","year":"2022","journal-title":"Ukrainian journal of veterinary and agricultural sciences"},{"key":"pone.0307615.ref005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/v14051094","article-title":"Human Retrovirus Genomic RNA Packaging","volume":"14","author":"HM Hanson","year":"2022","journal-title":"Viruses"},{"key":"pone.0307615.ref006","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajt.2022.12.013","article-title":"Infection and clinical xenotransplantation: Guidance from the Infectious Disease Community of Practice of the American Society of Transplantation","volume":"23","author":"SA Mehta","year":"2023","journal-title":"American Journal of Transplantation"},{"key":"pone.0307615.ref007","first-page":"1","article-title":"An in silico approach to target RNA-dependent RNA polymerase of COVID-19 with naturally occurring phytochemicals","author":"HS Mahrosh","year":"2021","journal-title":"JE, Development, Sustainability"},{"key":"pone.0307615.ref008","first-page":"104146","article-title":"Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus","author":"K Chojnacka","year":"2020","journal-title":"JJoFF"},{"key":"pone.0307615.ref009","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/17460441.2020.1722636","article-title":"Metabolomic tools used in marine natural product drug discovery","volume":"15","author":"KA Stuart","year":"2020","journal-title":"Expert opinion on drug discovery"},{"key":"pone.0307615.ref010","doi-asserted-by":"crossref","first-page":"3946320221142793","DOI":"10.1177\/03946320221142793","article-title":"Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies","volume":"36","author":"M Azeem","year":"2022","journal-title":"Int J Immunopathol Pharmacol"},{"key":"pone.0307615.ref011","first-page":"2317","volume":"33","author":"G Mustafa","year":"2020","journal-title":"Screening and molecular docking of selected phytochemicals against NS5B polymerase of hepatitis C virus"},{"key":"pone.0307615.ref012","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/978-981-13-6920-9_25","volume-title":"Phytochemistry: An in-silico and in-vitro Update","author":"R Kumar","year":"2019"},{"key":"pone.0307615.ref013","first-page":"663","volume":"580","author":"C Gorgulla","year":"2020","journal-title":"An open-source drug discovery platform enables ultra-large virtual screens"},{"key":"pone.0307615.ref014","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.3390\/ijms231911131","article-title":"Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox Virus","volume":"23","author":"MK Dassanayake","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"pone.0307615.ref015","first-page":"173430","article-title":"In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2","volume":"886","author":"RR Deshpande","year":"2020","journal-title":"JEjop"},{"key":"pone.0307615.ref016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/computation10010007","article-title":"Virtual combinatorial library screening of quinadoline B derivatives against SARS-CoV-2 RNA-dependent RNA polymerase","volume":"10","author":"S Brogi","year":"2022","journal-title":"Computation"},{"key":"pone.0307615.ref017","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/1386207325666210917113207","article-title":"Polyphenolic natural products active in silico against SARS-CoV-2 spike receptor binding domains and non-structural proteins-a review","volume":"26","author":"MT Quimque","year":"2023","journal-title":"Combinatorial Chemistry & High Throughput Screening"},{"key":"pone.0307615.ref018","article-title":"The potential of anti-coronavirus plant secondary metabolites in COVID-19 drug discovery as an alternative to repurposed drugs: a review","author":"Z Alipour","year":"2023","journal-title":"Planta Medica"},{"key":"pone.0307615.ref019","first-page":"779","volume":"368","author":"Y Gao","year":"2020","journal-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus"},{"key":"pone.0307615.ref020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-020-20542-0","article-title":"Mechanism of SARS-CoV-2 polymerase stalling by remdesivir","volume":"12","author":"G Kokic","year":"2021","journal-title":"Nature Communications"},{"key":"pone.0307615.ref021","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/molecules29050978","article-title":"A Marine Natural Product, Harzianopyridone, as an Anti-ZIKV Agent by Targeting RNA-Dependent RNA Polymerase","volume":"29","author":"K Zhang","year":"2024","journal-title":"Molecules"},{"key":"pone.0307615.ref022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"NM O\u2019Boyle","year":"2011","journal-title":"Journal of Cheminformatics"},{"key":"pone.0307615.ref023","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s42003-019-0706-x","article-title":"Elucidating molecular interactions of L-nucleotides with HIV-1 reverse transcriptase and mechanism of M184V-caused drug resistance","volume":"2","author":"M Hung","year":"2019","journal-title":"Communications Biology"},{"key":"pone.0307615.ref024","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1093\/nar\/gku632","article-title":"Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention","volume":"42","author":"A Ahmed-Belkacem","year":"2014","journal-title":"Nucleic Acids Research"},{"key":"pone.0307615.ref025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-022-05271-2","article-title":"Structure of the Ebola virus polymerase complex","volume":"610","author":"B Yuan","year":"2022","journal-title":"Nature"},{"key":"pone.0307615.ref026","doi-asserted-by":"crossref","first-page":"e1005737","DOI":"10.1371\/journal.ppat.1005737","article-title":"Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling","volume":"12","author":"SP Lim","year":"2016","journal-title":"PLOS Pathogens"},{"key":"pone.0307615.ref027","first-page":"455","volume":"31","author":"O Trott","year":"2010","journal-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading"},{"key":"pone.0307615.ref028","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1016\/j.bmc.2016.07.060","article-title":"Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors","volume":"24","author":"T Oyama","year":"2016","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"pone.0307615.ref029","unstructured":"Design LJBC (2014) Pharmacophore and ligand-based design with Biovia Discovery Studio\u00ae."},{"key":"pone.0307615.ref030","first-page":"337","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"CA Lipinski","year":"2004","journal-title":"JDdtT"},{"key":"pone.0307615.ref031","first-page":"1067","volume":"35","author":"H Yang","year":"2019","journal-title":"admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties"},{"key":"pone.0307615.ref032","first-page":"84","author":"KJ Bowers","year":"2006","journal-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters"},{"key":"pone.0307615.ref033","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"LG Ferreira","year":"2015","journal-title":"Molecules"},{"key":"pone.0307615.ref034","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.tibs.2019.06.004","article-title":"Bringing molecular dynamics simulation data into view","volume":"44","author":"PW Hildebrand","year":"2019","journal-title":"Trends in Biochemical Sciences"},{"key":"pone.0307615.ref035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/life11020077","article-title":"Identification of lead compounds against Scm (fms10) in Enterococcus faecium using computer aided drug designing","volume":"11","author":"MA Rasheed","year":"2021","journal-title":"Life"},{"key":"pone.0307615.ref036","first-page":"1","article-title":"Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) inhibitors using PubChem molecular fingerprints","author":"M Rudrapal","year":"2024","journal-title":"Molecular Diversity"},{"key":"pone.0307615.ref037","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.sjbs.2021.12.018","article-title":"Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness\/ADMET studies","volume":"29","author":"M Rudrapal","year":"2022","journal-title":"Saudi journal of biological sciences"},{"key":"pone.0307615.ref038","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field","volume":"6","author":"D Shivakumar","year":"2010","journal-title":"Journal of chemical theory and computation"},{"key":"pone.0307615.ref039","first-page":"1","article-title":"Brazilian Medicinal Plants and Their Metabolites as Potential Antivirals Against SARS-CoV-2: a Systematic Review of Experimental Findings","author":"DA Fernandes","year":"2024","journal-title":"Revista Brasileira de Farmacognosia"},{"key":"pone.0307615.ref040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/978-3-031-08045-6_25","volume-title":"Frontiers of COVID-19: Scientific and Clinical Aspects of the Novel Coronavirus 2019","author":"MTJ Quimque","year":"2022"},{"key":"pone.0307615.ref041","doi-asserted-by":"crossref","first-page":"104146","DOI":"10.1016\/j.jff.2020.104146","article-title":"Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus","volume":"73","author":"K Chojnacka","year":"2020","journal-title":"Journal of Functional Foods"},{"key":"pone.0307615.ref042","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.tim.2023.03.008","article-title":"Interplay between endogenous and exogenous human retroviruses","volume":"31","author":"E Kyriakou","year":"2023","journal-title":"Trends in Microbiology"},{"key":"pone.0307615.ref043","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00203-024-03846-3","article-title":"Fighting nature with nature: Antiviral compounds that target retroviruses","volume":"206","author":"ZY Siew","year":"2024","journal-title":"Archives of Microbiology"},{"key":"pone.0307615.ref044","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/molecules28062470","article-title":"Food plant secondary metabolites antiviral activity and their possible roles in SARS-CoV-2 treatment: an overview","volume":"28","author":"D Giordano","year":"2023","journal-title":"Molecules"},{"key":"pone.0307615.ref045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s13659-020-00257-x","article-title":"Research Progress of the Antiviral Bioactivities of Natural Flavonoids","volume":"10","author":"L Wang","year":"2020","journal-title":"Natural Products and Bioprospecting"},{"key":"pone.0307615.ref046","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/molecules22081337","article-title":"A Review of the Antiviral Role of Green Tea Catechins","volume":"22","author":"J Xu","year":"2017","journal-title":"Molecules"},{"key":"pone.0307615.ref047","first-page":"5277","article-title":"Synthesis, virtual screening and computational approach of a quinoxaline derivative as potent anti-HIV agent targeting the reverse transcriptase enzyme","volume":"41","author":"Y El Bakri","year":"2023","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"pone.0307615.ref048","first-page":"540","article-title":"Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease & reverse transcriptase activity","volume":"137","author":"M Modi","year":"2013","journal-title":"The Indian journal of medical research"},{"key":"pone.0307615.ref049","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbiotec.2019.12.016","article-title":"Hydroxytyrosol: A natural compound with promising pharmacological activities","volume":"309","author":"M Bertelli","year":"2020","journal-title":"Journal of Biotechnology"},{"key":"pone.0307615.ref050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.antiviral.2018.04.008","article-title":"Caffeic acid inhibits HCV replication via induction of IFN\u03b1 antiviral response through p62-mediated Keap1\/Nrf2 signaling pathway","volume":"154","author":"J Shen","year":"2018","journal-title":"Antiviral Research"},{"key":"pone.0307615.ref051","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.antiviral.2015.04.003","article-title":"Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry","volume":"118","author":"W-C Hsu","year":"2015","journal-title":"Antiviral Research"},{"key":"pone.0307615.ref052","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1038\/s41598-017-04358-5","article-title":"Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry","volume":"7","author":"M Bose","year":"2017","journal-title":"Scientific Reports"},{"key":"pone.0307615.ref053","first-page":"105948","article-title":"Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence","volume":"55","author":"L Wang","year":"2020","journal-title":"JIjoaa"},{"key":"pone.0307615.ref054","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ptr.6916","article-title":"Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells","volume":"35","author":"M Yang","year":"2021","journal-title":"Phytotherapy Research"},{"key":"pone.0307615.ref055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/v10090473","article-title":"Resveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview","volume":"10","author":"G Annunziata","year":"2018","journal-title":"Viruses"},{"key":"pone.0307615.ref056","author":"MM Castrillo","year":"2015","journal-title":"Effect of naringenin, hesperetin and their glycosides forms on the replication of the 17D strain of yellow fever virus"},{"key":"pone.0307615.ref057","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.3390\/molecules28237693","article-title":"Exploring the Potential of Plant Bioactive Compounds against Male Infertility: An In Silico and In Vivo Study","volume":"28","author":"M Jahangeer","year":"2023","journal-title":"Molecules"},{"key":"pone.0307615.ref058","doi-asserted-by":"crossref","first-page":"e0165767","DOI":"10.1371\/journal.pone.0165767","article-title":"Hydrogen bond dynamic propensity studies for protein binding and drug design","volume":"11","author":"CA Men\u00e9ndez","year":"2016","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T13:31:24Z","timestamp":1722864684000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307615"}},"subtitle":[],"editor":[{"given":"Chandrabose","family":"Selvaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0307615","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]}}}